Article
Genomic profiling of renal cell carcinoma in patients with end‐stage renal disease
6 Dec 2011
Abstract excerpt
The purpose of the present study was to determine the genomic profile of renal cell carcinoma (RCC) in end-stage renal disease (ESRD) by analyzing genomic copy number aberrations. Seventy-nine tumor samples from 63 patients with RCC-ESRD were analyzed by array comparative genomic hybridization using the Agilent Whole Human Genome 4 × 44K Oligo Micro Array (Agilent Technologies Inc., Palo Alto, CA, USA)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
